Murray law-based quantitative flow ratio for assessment of nonculprit lesions in patients with ST-segment elevation

Xinjian Li1,2,3,4, Lin Mi1,2,3,4, Juntao Duan1,2,3,4

  • 1Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.

Cardiology Journal
|July 8, 2024
PubMed

Insights

Quantitative Flow Ratio (μQFR) can assess nonculprit arteries in ST-Segment Myocardial Infarction (STEMI) patients. Acute μQFR measurements correlate well with staged assessments, proving its feasibility and value.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Imaging

Background:

  • Revascularization of nonculprit arteries is recommended for ST-Segment Elevation Myocardial Infarction (STEMI) patients.
  • Optimal therapeutic strategies for nonculprit lesions in STEMI remain unclear.
  • Quantitative Flow Ratio (μQFR) offers a novel, non-invasive method for assessing coronary artery stenosis severity.

Purpose of the Study:

  • To evaluate the feasibility and correlation of μQFR in assessing nonculprit arteries during the acute phase of STEMI.
  • To compare acute μQFR measurements with staged evaluations in STEMI patients.

Main Methods:

  • Retrospective analysis of STEMI patients who underwent staged percutaneous coronary intervention (PCI).
  • μQFR analysis of nonculprit vessels using both acute and staged coronary angiography.
  • Correlation and agreement assessment between acute and staged μQFR values.

Main Results:

  • 110 nonculprit arteries from 84 STEMI patients were analyzed.
  • A strong correlation (r=0.719) was observed between acute and staged μQFR.
  • High classification agreement (89.09%) and a significant area under the ROC curve (0.931) for detecting functionally significant lesions.

Conclusions:

  • Calculating μQFR during the acute phase of STEMI is feasible.
  • Acute and staged μQFR measurements demonstrate good correlation and agreement.
  • μQFR is a potentially valuable tool for assessing the functional significance of nonculprit arteries in STEMI patients.
Abstract